Sunil Agarwal - Net Worth and Insider Trading
Sunil Agarwal Net Worth
The estimated net worth of Sunil Agarwal is at least $17 Million dollars as of 2024-09-04. Sunil Agarwal is the EVP, Head of Development & CMO of Sana Biotechnology Inc and owns about 1,550,000 shares of Sana Biotechnology Inc (SANA) stock worth over $9 Million. Sunil Agarwal is the President of R & D of Juno Therapeutics Inc and owns about 84,549 shares of Juno Therapeutics Inc (JUNO) stock worth over $7 Million. Sunil Agarwal is also the Chief Medical Officer of Ultragenyx Pharmaceutical Inc and owns about 9,528 shares of Ultragenyx Pharmaceutical Inc (RARE) stock worth over $530,805. Details can be seen in Sunil Agarwal's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Sunil Agarwal has not made any transactions after 2021-09-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Sunil Agarwal
Sunil Agarwal Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Sunil Agarwal owns 6 companies in total, including MyoKardia Inc (MYOK) , Calithera Biosciences Inc (CALA) , and Juno Therapeutics Inc (JUNO) among others .
Click here to see the complete history of Sunil Agarwal’s form 4 insider trades.
Insider Ownership Summary of Sunil Agarwal
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
MYOK | MyoKardia Inc | 2020-06-18 | director |
CALA | Calithera Biosciences Inc | 2016-06-14 | director |
JUNO | Juno Therapeutics Inc | 2018-03-05 | President of R & D |
![]() | ![]() | 2016-07-21 | Chief Medical Officer |
![]() | ![]() | 2021-09-16 | See Remarks |
![]() | ![]() | 2023-06-15 | director |
Sunil Agarwal Latest Holdings Summary
Sunil Agarwal currently owns a total of 3 stocks. Among these stocks, Sunil Agarwal owns 1,550,000 shares of Sana Biotechnology Inc (SANA) as of September 16, 2021, with a value of $9 Million and a weighting of 52.38%. Sunil Agarwal owns 84,549 shares of Juno Therapeutics Inc (JUNO) as of October 2, 2017, with a value of $7 Million and a weighting of 44.41%. Sunil Agarwal also owns 9,528 shares of Ultragenyx Pharmaceutical Inc (RARE) as of July 21, 2016, with a value of $530,805 and a weighting of 3.21%.
Latest Holdings of Sunil Agarwal
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
SANA | Sana Biotechnology Inc | 2021-09-16 | 1,550,000 | 5.60 | 8,672,250 |
JUNO | Juno Therapeutics Inc | 2017-10-02 | 84,549 | 86.96 | 7,352,381 |
RARE | Ultragenyx Pharmaceutical Inc | 2016-07-21 | 9,528 | 55.71 | 530,805 |
Holding Weightings of Sunil Agarwal
Sunil Agarwal Form 4 Trading Tracker
According to the SEC Form 4 filings, Sunil Agarwal has made a total of 1 transactions in Sana Biotechnology Inc (SANA) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Sana Biotechnology Inc is the sale of 60,000 shares on September 16, 2021, which brought Sunil Agarwal around $2 Million.
According to the SEC Form 4 filings, Sunil Agarwal has made a total of 0 transactions in Juno Therapeutics Inc (JUNO) over the past 5 years. The most-recent trade in Juno Therapeutics Inc is the sale of 7,285 shares on October 2, 2017, which brought Sunil Agarwal around $326,077.
According to the SEC Form 4 filings, Sunil Agarwal has made a total of 0 transactions in Ultragenyx Pharmaceutical Inc (RARE) over the past 5 years. The most-recent trade in Ultragenyx Pharmaceutical Inc is the sale of 649 shares on July 21, 2016, which brought Sunil Agarwal around $34,189.
Insider Trading History of Sunil Agarwal
- 1
Sunil Agarwal Trading Performance
Sunil Agarwal Ownership Network
Sunil Agarwal Owned Company Details
What does MyoKardia Inc do?
Who are the key executives at MyoKardia Inc?
Sunil Agarwal is the director of MyoKardia Inc. Other key executives at MyoKardia Inc include director & President and CEO Anastasios Gianakakos , General Counsel Denelle J Waynick , and Chief Business Officer Jake Bauer .
MyoKardia Inc (MYOK) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of MyoKardia Inc (MYOK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of MyoKardia Inc (MYOK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
MyoKardia Inc (MYOK)'s detailed insider trading history can be found in Insider Trading Tracker table.
MyoKardia Inc Insider Transactions
Sunil Agarwal Mailing Address
Above is the net worth, insider trading, and ownership report for Sunil Agarwal. You might contact Sunil Agarwal via mailing address: 60 Leveroni Court, Novato Ca 94949.